NCT02823925View on ClinicalTrials.gov

Bisphosphonate Therapy in MONA Spectrum Disorder

CompletedOBSERVATIONAL

Enrollment

3

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

January 31, 2015

Conditions

Bone DensityPainFracture

Interventions

DRUG

Pamidronate or Zoledronate

All Listed Sponsors

lead

Medical University Innsbruck

OTHER

NCT02823925 - Bisphosphonate Therapy in MONA Spectrum Disorder | Biotech Hunter | Biotech Hunter